Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Supriya Lifescience Ltd.
Swot
Supriya Lifescience Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Supriya Lifescience Ltd. has 25 Strengths, 4 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(25)
Weakness
(4)
Opportunity
(3)
Threats
(2)
Others
(4)
MACD Crossover Above Signal Line
Companies with no Debt
High DVM Mid and Small Caps (subscription)
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 4 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
RSI indicating price strength
MACD crossed above signal line previous end of day
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Companies with growing costs YoY for long term projects
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Brokers upgraded recommendation or target price in the past three months
FII / FPI or Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs decreased their shareholding last quarter
Insiders sold stocks
High Piotroski Score - Companies with strong financials
Rising Delivery Percentage Compared to Prev Day
High Piotroski Score with High Return on Equity (ROE) and EPS Growth
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
